Artificial intelligence (AI) has the potential to transform the pharmaceutical industry. Each of the major pharma players is investing in the technology at some level, and there are a growing number of applications that address target and drug discovery, preclinical and clinical development, and postapproval activities.
Only logged in customers who have purchased this product may leave a review.
You may also like
As the game industry continues to grow and expand its target market to nearly every person with access to an Internet connection, the capabilities needed to gain a competitive advantage are changing too.
The Pulse of Gaming$0.00 Accenture
SUPPLY chains traditionally are linear in nature, with a discrete progression of design, plan, source, make, and deliver. Today, however, many supply chains are transforming from a staid sequence to a dynamic, interconnected system that can more readily incorporate ecosystem partners and evolve to a more optimal state over time.
The rise of the digital supply network$0.00 Deloitte
In 2007, medical leaders from across the pharmaceutical industry assembled to develop a common understanding of a ten-year vision for Medical Affairs. With five years now past, it is hardly surprising that significant change has occurred in the world in which the pharmaceutical industry operates, especially given the remarkable economic environment and the continued acceleration of technological change.
Pharma Medical Affairs 2020 and beyond$0.00 McKinsey
Trouble with Conavigo
Want to refine your results?
Help with Sourcing
Need help with your Sourcing?
Want to join our Community?
- This Week In Consulting: How do Travel & Hospitality cope with the Covid crisis?by Hélène Laffitte on October 28, 2020 at 7:36 am
This Week in Consulting - Curated News on the Consulting Industry published every Wednesday brought to you by Consulting Quest. This week,October 28th ,2020, […]